ANI Pharmaceuticals Inc (NASDAQ:ANIP)
| 55.97 Data as of Jan 30 |  -1.83 / -3.17%Today’s Change | 19.51 Today|||52-Week Range 61.43 | -0.74% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 4 2013 | Quarter 1 2014 | Quarter 2 2014 | Quarter 3 2014 | |||
| Revenue and Income | Net Revenues | 10.5M | 10.9M | 6.6M | 17.4M | |
| Cost of Goods Sold | 2.9M | 2.6M | 2.1M | 3.1M | ||
| Depreciation And Amortization | 437.2K | 703.0K | 706.0K | 1.2M | ||
| Operating Expenses | Gross Income | 7.2M | 7.6M | 3.8M | 13.1M | |
| General Expenses | 3.7M | 4.1M | 6.3M | 4.9M | ||
| Research And Development | 524.5K | 376.0K | 851.0K | 883.0K | ||
| Total Operating Expenses | 7.1M | 7.4M | 9.1M | 9.2M | ||
| Non-Operating Expenses | Operating Income | 3.5M | 3.5M | -2.5M | 8.2M | |
| Extraordinary Charge | -- | 0.00 | -60.0K | 0.00 | ||
| Interest Expense On Debt | 98.00 | 0.00 | -- | -- | ||
| Other Expenses | 31.4K | 29.0K | 21.0K | 82.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 3.5M | 3.5M | -2.5M | 8.3M | |
| Income Taxes | -102.9K | -165.0K | -133.0K | -1.5M | ||
| Preferred Dividend | -801.00 | 0.00 | 0.00 | 0.00 | ||
| Discontinued Operations | 44.7K | 0.00 | 0.00 | 0.00 | ||
| Net Income | 3.4M | 3.3M | -2.4M | 6.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 9.5M | 10.0M | 11.2M | 11.2M | |
| Shares To Calculate EPS Diluted | 9.5M | 10.0M | 11.2M | 11.3M | ||
| Earnings Per Share | EPS | $0.36 | $0.33 | -$0.21 | $0.59 | |
| EPS Diluted | $0.36 | $0.33 | -$0.21 | $0.59 | ||
.